Physician profile

Shiraz A Daud

Pulmonary Disease · Saint Louis, MO

NPI 1346206612

$67,472.10

in general payments reported to CMS, 2019-2025

49 companies · $2,398 in 2025

The $2,398 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

See the full distribution for Pulmonary Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,164.24
Travel and Lodging$2,452.90
Consulting Fee$17.69
Education$8.25

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mylan Specialty L.P. $27,078.95 2019-2024 Yupelri
Sunovion Pharmaceuticals INC. $20,795.34 2019
Astrazeneca Pharmaceuticals LP $4,837.55 2019-2025 Airsupra, Breztri, Tezspire
Inspire Medical Systems, INC. $3,751.40 2023-2025 Inspire
Glaxosmithkline, LLC. $2,387.48 2019-2025 Trelegy Ellipta, Arexvy, Nucala
Boehringer Ingelheim Pharmaceuticals, INC. $1,619.05 2019-2025 Ofev, Spiriva Respimat, Stiolto Respimat
Actelion Pharmaceuticals US, INC. $1,300.69 2019-2025 Opsumit, Uptravi, Opsynvi
Insmed, INC. $782.16 2020-2025 Arikayce, Brinsupri
Genzyme Corporation $473.60 2020-2025
Electromed, INC. $391.89 2019-2025 Smartvest
Philips North America LLC $375.52 2019-2025 (8874) Incourage, Vest Therapy Und, Encore
Grifols USA, LLC $360.42 2019-2025 Prolastin-C Liquid
Regeneron Healthcare Solutions, INC. $299.88 2019-2025 Dupixent
Merck Sharp & Dohme LLC $265.41 2019-2025 Zerbaxa, Winrevair, Keytruda
United Therapeutics Corporation $249.94 2019-2025 Tyvaso, Tyvaso
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Harmony Biosciences LLC $242.78 2021-2025
Amgen INC. $217.13 2022-2025 Tezspire, Tavneos
Bayer Healthcare Pharmaceuticals INC. $192.95 2019-2023
Pulmonx Corporation $184.10 2023 Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve
Tactile Systems Technology INC $153.66 2024-2025 Flexitouch Plus, Entre Plus, Nimbl
Baxter Healthcare $122.87 2025 Hillrom - Vest System Model 105 Home Care
La Jolla Pharmaceutical Company $116.40 2021
Axsome Therapeutics, INC. $99.63 2023-2025 Sunosi
Takeda Pharmaceuticals U.S.A., INC. $93.31 2021-2024 Glassia
Pfizer INC. $91.02 2020-2025
E.R. Squibb & Sons, L.L.C. $87.26 2019-2022
Novartis Pharmaceuticals Corporation $87.16 2019-2024
Fisher & Paykel Healthcare INC $75.44 2020-2025 Fisher & Paykel Healthcare
Abbvie INC. $73.53 2024-2025
Advanced Respiratory, INC $71.93 2019-2020
Genentech USA, INC. $62.41 2019-2021
Ani Pharmaceuticals, INC. $60.36 2024 Purified Cortrophin Gel
Jazz Pharmaceuticals INC. $58.30 2019-2022
Lilly USA, LLC $43.69 2025 Zepbound
Janssen Pharmaceuticals, INC $41.52 2020-2022
Intuitive Surgical, INC. $37.82 2025
Csl Behring $33.92 2024 Hizentra
Viatris Specialty LLC $33.43 2025 Yupelri
3b Medical, INC. $31.71 2024 Luna
Paratek Pharmaceuticals, INC. $27.85 2023 Nuzyra
Itamar Medical INC $24.70 2025 Watchpatone
Hospira, INC. $24.33 2025
Janssen Biotech, INC. $21.65 2025 Tremfya
Verona Pharma, INC. $18.92 2025 Ohtuvayre
Adma Biomanufacturing LLC $17.69 2025
Apria Healthcare LLC $14.46 2021
Resmed Corp $14.34 2019
Inari Medical, INC. $14.10 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Cumberland Pharmaceuticals, INC. $12.45 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Shiraz A Daud

$67,472.10

in general payments reported 2019-2025

Years
2019-2025
Top company
Mylan Specialty L.P.
Context
The $2,398 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/332437/shiraz-a-daud

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.